Compugen Ltd. ( CGEN) - Key Metrics
CGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.07 | $0 | $0 |
| 2026Q1 | $0.02 | -$0.08 | $0 | $0 |
| 2025Q4 | $0.71 | $0.60 | $0 | $0 |
| 2025Q3 | $0.02 | -$0.07 | $0 | $0 |
| 2025Q2 | $0.01 | -$0.08 | $0 | $0 |
CGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.64 |
| 2026Q1 | 0% | -6.66 |
| 2025Q4 | 0% | 0.64 |
| 2025Q3 | 0% | -4.93 |
| 2025Q2 | 0% | -5.67 |
CGEN
Price: $1.98
52 week price:
Earnings Per Share: 0.38 USD
P/E Ratio: 6.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 1.0 million
Ebitda: -10.0 millionMarket Capitalization: 218.4 million